This website uses cookies
We use cookies to improve your experience and analyse site usage. By clicking "Accept all cookies", you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
Close Cookie Preference Manager
Cookie
We use cookies to improve your experience and analyse site usage. By clicking 'Accept all cookies', you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
Strictly necessary (always active)
Cookies required to enable basic website functionality.
Accept all cookiesSave settings

InnotiveDx presents at LSI Europe ’24

20 September 2024

InnotiveDx (formerly PhenUtest) was delighted to attend LSI Europe ’24 in Portugal this week.

On Thursday 19th September, our CEO, Will Wijnberg, presented the InnotiveDx story to delegates. It was great to be able to present to and connect with so many like-minded innovators and investors.

If you are interested in following up with InnotiveDx to discover more about our product and future plans, then please get in contact with our team.

The latest from us

InnotiveDx longlisted for the Nature Spinoff Prize

The Spinoff Prize is a global award for early-stage university spinoffs that turn scientific research into impactful products and services.

10 June 2024

InnotiveDx secures place on Texas Medical Center Innovation Accelerator

InnotiveDx is set to benefit from expert mentorship and resources to enhance its market entry strategy for its rapid UTI diagnostic system.

31 May 2024

InnotiveDx completes seed fundraising of £3.2m

InnotiveDx has secured seed funding to advance its groundbreaking UTI diagnostic system and tackle the growing challenge of antimicrobial resistance.

22 March 2024

InnotiveDx shortlisted for BioNow Start-Up Award 2023

InnotiveDx is proud to be shortlisted for the BioNow Start-Up Award 2023, highlighting its pioneering work in rapid UTI diagnostics.

6 February 2024